• Company
• Will AML drug Xospata be reimbursed through PE exemption?
• by Eo, Yun-Ho Aug 18, 2021 05:52am

• Company
• Hanmi & Organon maintain ₩70 billion worth contract
• by Kim, Jin-Gu Aug 18, 2021 05:52am

• Policy
• Indication extensions filed by Abilify generics increase
• by Lee, Tak-Sun Aug 18, 2021 05:51am

• Policy
• Moderna apologized to the gov for the disruption in supply
• by Kim, Jung-Ju Aug 18, 2021 05:51am

• Company
• Will GSK-SK Bioscience distribute flu vaccines?
• by Aug 18, 2021 05:51am

• Company
• Medication imports in July are the largest ever
• by Kim, Jin-Gu Aug 17, 2021 05:53am

• Company
• Insulin·GLP-1 combo Xultophy lands in ‘Big 5’ hospitals
• by Eo, Yun-Ho Aug 17, 2021 05:52am

• Policy
• Opdivo's RSA renewed… benefit extended for use with Yervoy
• by Lee, Hye-Kyung Aug 17, 2021 05:52am

• Policy
• SK Chemical will sell Zemplar
• by Lee, Tak-Sun Aug 17, 2021 05:52am

• Policy
• GBP510 has been approved for Phase 3, the 1st time in Korea
• by Lee, Tak-Sun Aug 17, 2021 05:52am